Dear Label_Name,

Greetings! I hope you are well.

I am writing on behalf of an international publishing house, Science and Education Publishing, USA (http://www.sciepub.com).

Science and Education Publishing (SciEP) is a multidisciplinary open access publisher of Journals covering the fields of Science, Technology and Medicine. All SciEP publications are subject to high-quality peer review, editorial and production processes and are freely available online.

Welcome to the April, 2013 edition of SciEP newsletter, providing monthly summaries of articles on science & education related topics of interest to scientist and professionals. The mission of our journals is to provide an open access forum for publishing new findings on issues pertinent to scientific and academic field. We also invite you to submit original research papers, review articles, short reports, or case studies are considered for publication in our Multidisciplinary Journals.

American Journal of Public Health Research
DOI: 10.12691/ajphr-1-1-3

The Implementation of a Tele-Homecare System with Service Oriented Architecture and HL7 Message Transmission Standard
Ching-Sung Wang

American Journal of Medical and Biological Research
DOI: 10.12691/ajmbr-1-1-2

The Influence of Ethanol on Pyruvate Kinases Activity in Vivo, in Vitro, in Silico
Lelevich Sergey Vladimirovich, Khrustalev Vladislav Victorovich, Barkovsky Eugene Victorovich, Shedogubova Tatyana Aleksandrovna

American Journal of Medical Sciences and Medicine
DOI: 10.12691/ajmsm-1-1-1

Clinical and Histological Features in Wegener Granulomatosis
Li Cavoli Gioacchino, Passantino Rita, Bono Luisa, Tortorici Calogera, Ferrantelli Angelo, Giammarresi Carlo, Rotolo Ugo

American Journal of Infectious Diseases and Microbiology
DOI: 10.12691/ajidm-1-1-2

The Curse of Lymphatic Filariasis: Would the Continual Use of Diethylcarbamazine Eliminate this Scourge in Papua New Guinea?
Anne Lanham, Lillian Mwanri

We have released issues of some journals on February 2013.
American Journal of Public Health Research
American Journal of Medical Sciences and Medicine
American Journal of Medical and Biological Research
American Journal of Pharmacological Sciences
American Journal of Clinical Medicine Research
American Journal of Nursing Research
American Journal of Cancer Prevention
American Journal of Medicine Studies
American Journal of Infectious Diseases and Microbiology
American Journal of Cardiovascular Disease Research
American Journal of Biomedical Research
American Journal of Mechanical Engineering
American Journal of Microbiological Research
Journal of Preventive Medicine
American Journal of Food and Nutrition
American Journal of Hypertension Research
American Journal of Sports Science and Medicine
Journal of Cancer Research and Treatment
American Journal of Zoological Research
Journal of Biomedical Engineering and Technology
American Journal of Microbiological Research
Biomedical Science and Engineering

We are pleased to announce that submissions are now being accepted for peer review for all the journals across all our subject areas in SciEP.

Please submit your manuscript via our online submission system:
http://www.sciepub.com/author/signin

To unsubscribe from our mailing list, please click on the following link: unsubscribe

I am looking forward to hearing from you.

Kind regards,

David Rain
Email:join@sciepub.com
Science and Education Publishing (http://www.sciepub.com)

Recurrent Marijuana Induced Myocarditis: A Case Report

Sabina Kumar*, John Carvalho, Chukwuemeka Umeh, Pranav BarveJose Penaherrera, Ratan Tiwari, Shivang Shah

Department of Internal Medicine, Hemet Global Medical Center, Hemet, California, USA

Abstract: Thirty-Three states in the US have passed laws to legalize marijuana usage, increasing its prevalence by 50% within the last year. Though society generally regards cannabis as safe, the exponential increase in users can evince dangerous side effects in patients presenting to physicians, such as the case presented below. A 37-year-old female presented to the ED with chest pain and an initial troponin of 24 that peaked at 29. The coronary arteries were found to be angiographically normal. She was discharged without any definitive diagnosis. Now 38, she again presented with complaints of crushing, substernal chest pain radiating down her left arm, unrelieved by nitro. Since the onset of pain, she progressively developed shortness of breath, nausea, diaphoresis, and anxiety, stating that she felt like she “was going to die.” Her presentation and impending sense of doom were ominous harbingers for a myocardial infarction; concerns that were validated with an initial troponin of 11.4. EKG showed normal sinus rhythm with nonspecific ST changes. CT Angiogram showed no evidence of pulmonary thrombo-embolism or dissection. Significant CAD leading to this extent of troponin elevation was not suspected as the patient had a normal angiogram a year prior. Stress-Induced Cardiomyopathy was unlikely based on the unremarkable echocardiogram findings. Coronary-Thrombus was considered, however, the hypercoagulable workup was negative along with lack of coronary thrombus on prior angiogram. Under these circumstances, the only explanation for the extent of troponin elevation was myocarditis. Viral infections are the most common cause of myocarditis, however the patient denied any associated symptoms. After ruling out viral etiologies, we subsequently evaluated and eliminated rheumatological disorders and medication-induced myocarditis. The patient’s history revealed that she led a healthy lifestyle, but had struggled with chronic back pain, which led to her cannabis use. By the time of her admission, she smoked up to 1.5 grams of cannabis a day, and stated that chest pain began immediately following smoking cannabis. Her previous episodes also correlated with her cannabis usage. Given the strong correlation of the patient’s symptoms with cannabis use, we theorized her cardiac stress was resultant from it, and recommended that she discontinue its use. To date there have been four reported cases of cannabis-induced myocarditis, making this a fifth case. Of note, the contaminants of marijuana may be variable and include substances like aluminum from soil or pesticides in grass that could traverse the marijuana plant. Inhaling such components has been correlated with an upregulation of cannabinoid receptors in platelets, vascular smooth muscle, and endothelium. CB1R activation has been observed to induce oxidative stress, inflammation, and fibrosis of the cardiomyocyte. With increased cannabis use, it is imperative that we document adverse events to definitively connect its use to cardiac damage.

Keywords: marijana, myoarditis, cardiomyopathy

Received May 17, 2021; Revised June 21, 2021; Accepted July 01, 2021

Citation: Sabina Kumar, John Carvalho, Chukwuemeka Umeh, Pranav BarveJose Penaherrera, Ratan Tiwari, Shivang Shah, Recurrent Marijuana Induced Myocarditis: A Case Report. American Journal of Medical Case Reports, 9 (10). 519-521. January 2021. doi:10.12691/ajmcr-9-10-11

1. Introduction

Marijuana is the most used recreational drug in the United States (US), and the number of users has increased over the years [1,2]. According to the National Survey on Drug Use and Health 2019, the percentage of people aged 12 or older who used marijuana in the past year increased from 11.0 percent (or 25.8 million people) in 2002 to 17.5 percent (or 48.2 million people) in 2019 [2]. Despite studies that have shown that marijuana may be helpful in treating neuropathic pain [1,3], marijuana use has been associated with deleterious consequences, including adverse effects on the brain, lungs, and heart [1]. Cases of marijuana associated cardiac arrhythmias, myocardial infarction, coronary dissection, and myopericarditis have been previously reported [4,5,6,7]. We report here a rare case of recurrent marijuana induced myocarditis in a young female patient.

2. Case Report

A 37-year-old female originally presented to the emergency department with crushing substernal chest pain which resolved after receiving nitroglycerin in the field. The vital signs and physical examination on presentation were grossly unremarkable. The labs were also unremarkable apart from an initial troponin of 24, which then peaked at 29. Her urine drug screen was positive for cannabinoids. The electrocardiogram (EKG) showed normal sinus rhythm with nonspecific ST changes. An echocardiogram showed grossly normal left ventricular systolic function with no definite wall motion abnormality and an ejection fraction of 55 to 60 percent. The coronary arteries were found to be angiographically normal (Figure 1). She was discharged without any definitive diagnosis. Now, at the age of 38, she again presented with complaints of crushing, substernal chest pain radiating down her left arm, this time unrelieved by nitro. Since the onset of her pain, she progressively developed shortness of breath, nausea, diaphoresis, and anxiety, stating that she felt like she “was going to die.” Her presentation and impending sense of doom were ominous harbingers for a myocardial infarction; concerns that were validated with an initial troponin of 11.4. EKG showed normal sinus rhythm with nonspecific ST changes. CT angiogram showed no evidence of pulmonary thrombo-embolism or dissection. Significant coronary artery disease leading to this extent of troponin elevation was not suspected, as the patient had a normal angiogram a year prior. Stress-Induced Cardiomyopathy was unlikely based on the unremarkable echocardiogram findings. Coronary-thrombus was considered, however, the hypercoagulable workup was negative along with lack of coronary thrombus on prior angiogram. Under these circumstances, the only explanation for the extent of troponin elevation was myocarditis. Viral infections are the most common cause of myocarditis, however the patient denied any associated symptoms. After ruling out viral etiologies, we subsequently evaluated and eliminated rheumatological disorders and medication-induced myocarditis. The patient’s history revealed that she led a healthy lifestyle, but had struggled with chronic back pain, which led to her cannabis use. By the time of her admission, she smoked up to 1.5 grams of cannabis a day, and stated that chest pain began immediately following smoking cannabis. Her previous episodes also correlated with her cannabis usage. Given the strong correlation of the patient’s symptoms with cannabis use, we theorized her cardiac stress was resultant from it, and recommended that she discontinue its use.

Figure 1. Coronary angiogram showing normal coronary arteries

3. Discussion

Myocarditis is an uncommon disease that presents with a wide range of symptoms and is an underdiagnosed cause of acute heart failure, sudden death, and chronic dilated cardiomyopathy [8,9]. Patients with myocarditis may present with chest pain, dyspnea, palpitations, fatigue, or syncope. Chest pain in acute myocarditis may mimic acute coronary syndrome, often with globally preserved left ventricular function, and patients may present with electrocardiographic changes, including ST-segment elevation [8,9]. Although viral infection is the most common cause of myocarditis, other infectious pathogens including bacteria, fungi, and protozoans, as well as toxins, drug reactions, autoimmune diseases, and sarcoidosis cause myocarditis [8,9].

Myocarditis is definitely diagnosed by histology irrespective of clinical presentation [9]. However, probable myocarditis can be diagnosed in a patient presenting with one of four clinical features consistent with acute myocarditis (acute heart failure, chest pain, presyncope or syncope, or myopericarditis), in addition to a recent trigger for myocarditis, and one of the following: (1) an unexplained rise in troponin; (2) electrocardiographic changes suggestive of acute myocardial injury; or (3) abnormal cardiac function on echocardiogram or cardiac MRI [9]. For our patient, her recurrent acute chest pain and unexplained rise in troponin were associated with a recent use of marijuana.

Marijuana induced myocarditis is rare and the exact mechanism through which marijuana causes myocarditis is unclear [10,11]. One possible explanation is that contaminants in street marijuana such as fungi, bacteria, heavy metals, and pesticides, are responsible [10,11]. Further research is needed to explain the cause of marijuana induced myocarditis; however, this is challenging in view of the rarity of the condition. Treatment for marijuana induced myocarditis includes stopping the use of marijuana and treating any associated complication from the disease such as heart failure.

In conclusion, we report a rare case of recurrent marijuana induced myocarditis. The fact that our patient was only diagnosed at her second presentation in the hospital with chest pain underscores the importance of physicians and cardiologists being aware of this rare and probably underdiagnosed cause of myocarditis.

References

[1]   | CDC. Marijuana: How Can It Affect Your Health? 2018. Available from: https://www.cdc.gov/marijuana/health-effects.html.

[2]  
Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55). Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Retrieved from https://www.samhsa.gov/data.

[3]   | National Academies of Sciences E, and Medicine. (2017). The health effects of cannabis and cannabinoids: Current state of evidence and recommendations for researchexternal icon. Washington, D.C.
[4]   | Kariyanna PT, Wengrofsky P, Jayarangaiah A, Haseeb S, Salciccioli L, Hegde S, Marmur JD, Soliman Y, Al-Bayati S, McFarlane SI. Marijuana and cardiac arrhythmias: A scoping study. International journal of clinical research & trials. 2019; 4(1).
[5]   | Kariyanna PT, Chandrakumar HP, Feit A, McFarlane IM. Marijuana-induced coronary vasospasm and myocardial infarction: a case report and review of literature. American journal of medical case reports. 2020; 8(7): 216.
[6]   | Kariyanna PT, Chandrakumar HP, Chowdhury YS, Jayarangaiah A, Das S, Jayarangaiah A, Salifu MO, McFarlane IM. Marijuana and Coronary Dissection: A Case Report and Review of Literature. American journal of medical case reports. 2021; 9(3): 172.
[7]   | Rodríguez-Castro CE, Alkhateeb H, Elfar A, Saifuddin F, Abbas A, Siddiqui T. Recurrent myopericarditis as a complication of marijuana use. The American journal of case reports. 2014; 15: 60.
[8]   | Blauwet LA, Cooper LT. Myocarditis. Progress in cardiovascular diseases. 2010 Jan 1; 52(4): 274-88.
[9]   | Sagar S, Liu PP, Cooper Jr LT. Myocarditis. The Lancet. 2012 Feb 25; 379(9817): 738-47.
[10]   | Tournebize J, Gibaja V, Puskarczyk E, Popovic B, Kahn JP. Myocarditis and cannabis: An unusual association. Toxicologie Analytique et Clinique. 2016 Sep 1; 28(3): 236.
[11]   | Kariyanna PT, Jayarangaiah A, Singh N, Song T, Soroka S, Amarnani A, Ray J, McFarlane SI. Marijuana induced myocarditis: a new entity of toxic myocarditis. American journal of medical case reports. 2018; 6(9): 169.